-
Extending the traditional 21/7 regimen of several forms of hormonal contraception has captured the attention of research scientists, and results of their investigations may lead to new approved uses of birth control drugs.
-
What are womens preferences when it comes to frequency and characteristics of menstrual bleeding in relation to reproductive status and oral contraceptive use? Here are highlights from a 2002 survey.
-
A young woman sits before you. She has an active lifestyle that requires her to travel a great deal. She is not interested in having children within the next year, and she is looking for convenient, effective contraception. What choices do you offer?
-
Are low-dose oral contraceptives (OCs) a safe form of birth control for women with well-controlled hypertension? What is the impact of weight on contraceptive efficacy?
-
As part of a growing trend of increased partnering by the Occupational Safety and Health Administration (OSHA), the Atlanta-based American Association of Occupational Health Nurses Inc. (AAOHN) and OSHA signed an alliance at the 2003 American Occupational Health Conference in Atlanta.
-
The Occupational Safety and Health Administration (OSHA) took center stage at the opening general session of the 2003 American Occupational Health Conference (AOHC) in Atlanta, with OSHA administrator John Henshaw hailing the new OSHA.
-
The recognition of non-accidental injury is critical for a pediatric
trauma patient. In the year 2000, almost 3 million reports of child
abuse were made to social service agencies. Forty-four percent of the
fatalities were children younger than 1 year of age. Not only are these
statistics alarming, but they point out the need for emergency
department and trauma physicians and nurses to recognize non-accidental
injury and aggressively protect the children who seek our medical
expertise and protection.
-
-
Pharmacist shortage continues despite lower vacancies; Scholarship campaign launched to recruit pharmacy teachers; Warnings added to topiramate and somatropin; ASHP speaks out againstmarket access bill
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):